Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Jul 31;184(8):513.
doi: 10.1007/s00431-025-06349-5.

Longitudinal changes in skeletal muscle in children undergoing cancer treatment: a systematic review and meta-analysis

Anna Maria Markarian  1   2 , Dennis R Taaffe  3   4 , Daniel A Galvão  3   4 , Carolyn J Peddle-McIntyre  3   4 , Jodie Cochrane Wilkie  3   4   5 , Francesco Bettariga  3   4 , Robert U Newton  3   4   6
Affiliations
Meta-Analysis

Longitudinal changes in skeletal muscle in children undergoing cancer treatment: a systematic review and meta-analysis

Anna Maria Markarian et al. Eur J Pediatr. .

Abstract

Skeletal muscle loss during chemotherapy has been associated with poorer outcomes and reduced survival across several types of cancer. However, the extent and progression of muscle loss during treatment for childhood cancers remain unclear. A better understanding could help identify children at increased risk and inform the timing of targeted intervention. This systematic review and meta-analysis aimed to synthesize the evidence on skeletal muscle changes during treatment for childhood cancers and identify factors that influence these outcomes. A systematic search was conducted in CINAHL, Embase, PubMed, SPORTDiscus, and Web of Science. Studies were eligible if they included children and adolescents (< 19 years) undergoing cancer treatment and reported muscle quantity at a minimum of two time points. The methodological quality of the included studies was evaluated using the Newcastle-Ottawa Scale. Twenty studies (n = 646; age range: 2.5-14.7 years) were included. A significant decline in muscle quantity was observed during the early phase of treatment (standardized mean difference (SMD): SMD = - 0.36; 95% CI: - 0.59 to - 0.13; p < 0.05). At later follow-up time points, the overall change was not statistically significant (SMD = - 0.08; 95% CI: - 0.27 to 0.10; p = 0.36). However, estimates of muscle quantity varied significantly by assessment modality (p = 0.048).

Conclusion: Children with cancer experience significant skeletal muscle loss during the intensive phase of treatment. While decrements observed at later time points appear modest, reported outcomes vary considerably depending on the assessment method. Standardized, reliable body composition measures are needed to detect meaningful changes and guide clinical care.

What is known: • Skeletal muscle loss during adult cancer treatment is linked to poor outcomes, yet pediatric data are limited and inconsistent.

What is new: • This is the first systematic review and meta-analysis showing significant early-phase skeletal muscle loss in children undergoing cancer treatment, accompanied by concurrent increases in fat mass. • Considerable variability in skeletal muscle estimates across different body composition assessment methods underscores the need for reliable and sensitive measurement techniques to monitor changes accurately and guide clinical care.

Keywords: Body composition; Childhood cancer; Skeletal muscle; Systematic review and meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of study selection process
Fig. 2
Fig. 2
Forest plots of changes in muscle quantity among children undergoing cancer treatment
Fig. 3
Fig. 3
Forest plot of changes in muscle quantity during the initial treatment phase in children diagnosed with cancer
Fig. 4
Fig. 4
Forest plots of changes in total body mass and fat mass among children undergoing cancer treatment
See this image and copyright information in PMC

References

    1. Scheede-Bergdahl C, Jagoe RT (2013) After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood. Front Pharmacol 4:49 - PMC - PubMed
    1. Armstrong GT et al (2016) Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374(9):833–842 - PMC - PubMed
    1. Bhakta N et al (2017) The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390(10112):2569–2582 - PMC - PubMed
    1. Scott JM et al (2018) Association of exercise with mortality in adult survivors of childhood cancer. JAMA Oncol 4(10):1352–1358 - PMC - PubMed
    1. Chang K-V et al (2017) Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer 7(1):90–103 - PMC - PubMed

Substances

LinkOut - more resources